Novel Topical photodynamic therapy of prostate carcinoma using hydroxy-aluminum phthalocyanine entrapped in liposomes

Anticancer Research

Volumn 33, Issue 4, 2013, Pages 1563-1568

  Sutoris, Karol ^a,b   Rakusan, Jan ^c   Karaskova, Marie ^c   Mattova, Jana ^a   Benes, Jiri ^a   Nekvasil, Milos ^d   Jezek, Petr ^d   Zadinova, Marie ^a   Pouckova, Pavla ^a   Vetvicka, David ^a,e  

^a CHARLES UNIVERSITY   (Czech Republic)

^b FAKULTNÍ THOMAYEROVA NEMOCNICE   (Czech Republic)

^c Centre for Organic Chemistry Ltd   (Czech Republic)

^d INSTITUTE OF PHYSIOLOGY   (Czech Republic)

^e CancerTech Ltd   (Czech Republic)

Author keywords

Liposomal photosensitizer; Photodynamic therapy; Phthalocyanine

Indexed keywords

HYDROXY ALUMINUM PHTHALOCYANINE; LIPOSOME; PHOTOSENSITIZING AGENT; PHTHALOCYANINE ALUMINUM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CANCER SIZE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; GEL; HUMAN; HUMAN CELL; IN VIVO STUDY; LIPOSOMAL DELIVERY; LOW DRUG DOSE; MALE; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROSTATE CARCINOMA; TOPICAL TREATMENT;

ADMINISTRATION, TOPICAL; ALUMINUM HYDROXIDE; ANIMALS; HUMANS; INDOLES; LIPOSOMES; MALE; MICE; MICE, NUDE; MOLECULAR STRUCTURE; ORGANOMETALLIC COMPOUNDS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PROSTATIC NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 84876767890     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Agostinis P, Berg K, Cengel KA, Foster TH, Girotti AW, Gollnick SO, Hahn SM, Hamblin MR, Juzeniene A, Kessel D, Korbelik M, Moan J, Mroz P, Nowis D, Piette J, Wilson BC and Golab J: Photodynamic therapy of cancer: An update. CA Cancer J Clin 61(4): 250-281, 2011.
2. Dolmans DE, Fukumura D and Jain RK: Photodynamic therapy for cancer. Nat Rev Cancer 3: 380-387, 2003. (Pubitemid 37328858)
3. Yoo JO and Ha KS: New insights into the mechanisms for photodynamic therapy - induced cancer cell death. Int Rev Cell Mol Biol 295: 139-174, 2012.
4. Mroz P, Hashmi JT, Huang YY, Lange N and Hamblin MR: Stimulation of antitumor immunity by photodynamic therapy. Expert Rev Clin Immunol 7: 75-91, 2011.
5. Kammerer R, Buchner A, Palluch P, Pongratz T, Oboukhovskij K, Beyer W, Johansson A, Stepp H, Baumgartner R and Zimmermann W: Induction of immune mediators in glioma and prostate cancer cells by non-lethal photodynamic therapy. PLoS One 6: e21834, 2011.
6. Moriwaki SI, Misawa J, Yoshinari Y, Yamada I, Takigawa M and Tokura Y: Analysis of photosensitivity in Japanese cancer-bearing patients receiving photodynamic therapy with porfimer sodium (Photofrin). Photodermatol Photoimmunol Photomed 17: 241-243, 2001. (Pubitemid 32834293)
7. Nekvasil M, Zadinova M, Tahotna L, Zackova M, Pouckova P and Jezek P: Optimum modality for photodynamic therapy of tumors: Gels containing liposomes with hydrophobic photosensitizers. Drug Dev Res 5: 235-252, 2007. (Pubitemid 350223934)
8. Bilgin MD, Elçin AE and Elçin YM: Topical use of liposomal copper palmitate formulation blocks porphyrin-induced photosensitivity in rats. J Photochem Photobiol 80: 107-114, 2005. (Pubitemid 40984409)
9. Zeitouni NC, Oseroff AR and Shieh S: Photodynamic therapy for non-melanoma skin cancers. Current review and update. Mol Immunol 39: 1133-1136, 2003. (Pubitemid 36776569)
10. Togsverd-Bo K, Lerche CM, Poulsen T, Wulf HC and Haedersdal M: Photodynamic therapy with topical methyl- and hexylaminolevulinate for prophylaxis and treatment of UV-induced SCC in hairless mice. Exp Dermatol 19: e166-172, 2010.
11. Baron ED, Malbasa CL, Santo-Domingo D, Fu P, Miller JD, Hanneman KK, Hsia AH, Oleinick NL, Colussi VC and Cooper KD: Silicon phthalocyanine (Pc 4) photodynamic therapy is a safe modality for cutaneous neoplasms: Results of a phase 1 clinical trial. Lasers Surg Med 42(10): 728-735, 2010.
12. Kyriazi M, Alexandratou E, Yova D, Rallis M and Trebst T: Topical photodynamic therapy of murine non-melanoma skin carcinomas with aluminum phthalocyanine chloride and a diode laser: Pharmacokinetics, tumor response and cosmetic outcomes. Photodermatol Photoimmunol Photomed 24: 87-94, 2008. (Pubitemid 351436830)
13. Kaestner L, Cesson M, Kassab K, Christensen T, Edminson PD, Cook MJ, Chambrier I and Jori G: Zinc octa-n-alkyl phthalo-cyanines in photodynamic therapy: Photophysical properties, accumulation and apoptosis in cell cultures, studies in erythrocytes and topical application to Balb/c mice skin. Photochem Photobiol Sci 2: 660-667, 2003. (Pubitemid 41646662)
14. Kalka K, Ahmad N, Criswell T, Boothman D and Mukhtar H: Up-regulation of clusterin during phthalocyanine 4 photodynamic therapy-mediated apoptosis of tumor cells and ablation of mouse skin tumors. Cancer Res 60: 5984-5987, 2000.
15. Hopper C: Photodynamic therapy: A clinical reality in the treatment of cancer. Lancet Oncol 1: 212-219, 2000.
16. Castano AP, Deminova TN and Hamblin MR: Mechanisms in photodynamic therapy: Part one - photosensitizers, photochemistry and cellular localization. Photodiag Photodyn Ther 4: 279-293, 2004. (Pubitemid 40460316)
17. Sutoris K, Vetvicka D, Horak L, Benes J, Nekvasil M, Jezek P, Zadinova M and Pouckova P: Evaluation of topical photodynamic therapy of mammary carcinoma with an experimental gel containing liposomal hydroxyl-aluminum phthalocyanine. Anticancer Res 32(9): 3769-3774, 2012.
18. Czech Patent No. 298978, Liposomal phthalocyanine gel preparation for photodynamic therapy of tumors and its procedure of preparation. Czech Office of Industrial Ownership, Prague, 2008.
19. Allison RR, Sibata C, Downie GH and Cuenca RE: Photodynamic therapy of the intact breast. Photodiag Photodyn Ther 3: 139-146, 2006. (Pubitemid 44143039)
20. Allison RR, Bagnato VS, Cuenca R, Downie GH and Sibata CH: The future of photodynamic therapy in oncology. Future Oncol 2: 53-71, 2006.
21. Roche JVE, Whitehurst C, Watt P, Moore JV and Krasner N: Photodynamic therapy (PDT) of gastrointestinal tumours: A new light delivery system. Laser Med Sci 13: 137-142, 1998. (Pubitemid 28347049)
22. Annemans L, Caekelbergh K, Roelandts R, Boonen H, Leys C, Nikkels AF, van Den Haute V, van Quickenborne L, Verhaeghe E and Leroy B: Real-life practice study of the clinical outcome and cost-effectiveness of photodynamic therapy using methyl aminolevulinate (MAL-PDT) in the management of actinic keratosis and basal cell carcinoma. Eur J Dermatol 18: 539-546, 2008.
23. Tran Cao HS, Kaushal S, Snyder CS, Ongkeko WM, Hoffman RM and Bouvet M: Real-time imaging of tumor progression in a fluorescent orthotopic mouse model of thyroid cancer. Anticancer Res 30: 4415-4422, 2010.
24. Vetvicka D, Hovorka O, Kovar L and Rihova B: Establishment of imageable model of T-cell lymphoma growing in syngenic mice. Anticancer Res 29: 4513-4517, 2009.
25. Kimura H, Lee C, Hayashi K, Yamauchi K, Yamamoto N, Tsuchiya H, Tomita K, Bouvet M and Hoffman RM: UV light killing efficacy of fluorescent protein-expressing cancer cells in vitro and in vivo. J Cell Biochem 110: 1439-1446, 2010.
26. Momiyama M, Suetsugu A, Kimura H, Kishimoto H, Aki R, Yamada A, Sakurada H, Chishima T, Bouvet M, Bulgakova NN, Endo I and Hoffman RM: Fluorescent proteins enhance UVC PDT of cancer cells. Anticancer Res 32: 4327-4330, 2012.